Abstract
This Practice Point commentary discusses Scharpé et al.'s single-center, nonrandomized, prospective trial of influenza vaccination in renal transplant recipients. In total, 165 transplant recipients and 41 healthy volunteers were vaccinated with a standard inactivated trivalent influenza vaccine (containing strains of the A/H1N1, A/H3N2 and B viruses). No rejection episodes or other adverse events were reported in either group. Influenza-specific antibody titers increased in renal transplant recipients following vaccination, as measured by comparison of pre-vaccination and post-vaccination seroprotection and seroresponse rates. This commentary discusses the limitations of the trial, and urges caution in extending the conclusions drawn by Scharpé et al. regarding the safety of the trivalent, non-adjuvant-containing influenza vaccine to newer adjuvant-assisted vaccines. Annual vaccination for influenza by use of the trivalent vaccine strategy without adjuvant should, however, be standard of care for all stable renal transplant recipients who do not have clinical contraindications.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Scharpé J et al. (2008) Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 8: 332–337
McKee AS et al. (2007) How do adjuvants work? Important considerations for new generation adjuvants. Immunity 27: 687–690
Guy B (2007) The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol 5: 505–517
Thornley TB et al. (2007) Type 1 IFN mediates cross-talk between innate and adaptive immunity that abrogates transplantation tolerance. J Immunol 179: 6620–6629
Huggins J et al. (2007) CpG DNA activation and plasma-cell differentiation of CD27− naive human B cells. Blood 109: 1611–1619
EBPG Expert Group on Renal Transplantation (2002) European best practice guidelines for renal transplantation: section IV: long-term management of the transplant recipient: IV.11 paediatrics (specific problems). Nephrol Dial Transplant 17 (Suppl 4): S55–S58
[No authors listed] (2004) Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 4 (Suppl 10): S160–S163
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Zand, M. Safety and efficacy of influenza vaccination in renal transplant recipients. Nat Rev Nephrol 4, 358–359 (2008). https://doi.org/10.1038/ncpneph0830
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0830